Cargando...
Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
BACKGROUND: The combination of gemcitabine and docetaxel (GT) has been demonstrated to be effective against various types of solid tumors, including sarcoma. However, the regimen has not been confirmed in large, well-designed clinical trials in refractory metastatic osteosarcoma. METHODS: We retrosp...
Guardado en:
| Publicado en: | BMC Cancer |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6192345/ https://ncbi.nlm.nih.gov/pubmed/30326879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4872-x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|